Who Just RaisedKloten, Switzerland · Health Care · Form D filed Aug 24, 2026
NewcelX Ltd. raised $2.9M
NewcelX Ltd. is a biotechnology company based in Kloten, Switzerland. In a Form D filed with the SEC on August 24, 2026, it reported raising $2,940,234 from 5 investors as part of an offering of up to $2,940,234. The first sale in the offering took place on July 3, 2026.
NewCelX Home
- 10th Form D since 2022. Earlier new notices: May 13, 2026 · Jul 10, 2025 · Apr 14, 2025 · Jan 22, 2025 · Oct 21, 2024 · Jul 15, 2024 and more. All filings on EDGAR
$33.6M raised since 2020
10 Form D offerings, as reported to the SEC, the first in Oct 14, 2022. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Aug 24, 2026 | $2.9M | $2.9M | 5 |
| May 13, 2026 | $3.4M | $3.4M | 4 |
| Jul 10, 2025 | $1M | $1M | 3 |
| Apr 14, 2025 | $2M | $2M | 3 |
| Jan 22, 2025 | $500K | $500K | 1 |
| Oct 21, 2024 | $7.2M | $7.2M | 6 |
| Jul 15, 2024 | $787K | $787K | 2 |
| Apr 3, 2024 | $1.8M | $1.8M | 2 |
and 2 earlier.
Placement agents: H.C. Wainwright & Co., LLC, Laidlaw & Company (UK) Ltd.
Lead score
11 out of 100
budget to spend website found
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Website
- newcelx.com
- Amount raised
- $2,940,234
- Offering size
- $2,940,234
- Investors so far
- 5
- First sale
- July 3, 2026
- Securities offered
- Equity, Options or warrants, Securities issuable on exercise or conversion, Other
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Kloten, Switzerland
- Incorporated
- Switzerland
- Entity type
- Other
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $2,940,234 | $2,940,234 | 5 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Aug 24, 2026 · August 2026 funding report
Similar raises
Estuary Biotherapeutics, Inc.
Menlo Park, CA · filed Oct 16First Form DStill raising
North Elam Ambulatory Surgery Center, LLC
Greensboro, NC · filed Oct 16First Form DStill raising
Immorta Bio, Inc.
Miami Beach, FL · filed Oct 162nd Form D since 2026Still raising
Lamina Surgical, Inc.
Oakland, CA · filed Oct 16
Making Open Surgery Safer | Lamina
First Form DStill raising
J3 Bioscience, Inc.
Salt Lake City, UT · filed Oct 1612th Form D since 2012
Ensho Therapeutics, Inc.
Woodcliff Lake, NJ · filed Oct 155th Form D since 2024Still raising
Light Wave Ownership Path, LLC
Raleigh, NC · filed Oct 1512th Form D since 2019
Immuno Cancer Biotherapeutics, Inc.
Canton, SD · filed Oct 15First Form D